Could tenofovir modify the model end-stage liver disease (MELD) score in patients with end-stage liver disease eligible for liver transplantation?
Bruno
Raffaele
R
Sacchi
Paolo
P
Filice
Gaetano
G
D000225:Adenine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D006801:Humans; D017093:Liver Failure / Q000188:drug therapy* / Q000473:pathology*; D016031:Liver Transplantation; D063065:Organophosphonates / Q000627:therapeutic use*; D012720:Severity of Illness Index; D000068698:Tenofovir
D019380:Anti-HIV Agents; D063065:Organophosphonates; D000068698:Tenofovir; D000225:Adenine